Evoke Pharma (EVOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,983 | -12,230 | -11,921 | -6,678 | -5,052 |
| Other Working Capital | -796 | 688 | 1,178 | 155 | -172 |
| Other Operating Activity | -40 | 2,825 | 4,760 | 2,740 | 3,537 |
| Operating Cash Flow | $-2,818 | $-8,717 | $-5,983 | $-3,783 | $-1,687 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 545 | 7,389 | 7,389 | 7,332 | 7,335 |
| Financing Cash Flow | $545 | $7,389 | $7,389 | $7,332 | $7,335 |
| Beginning Cash Position | 7,679 | 9,007 | 9,007 | 9,007 | 9,007 |
| End Cash Position | 5,406 | 7,679 | 10,413 | 12,556 | 14,655 |
| Net Cash Flow | $-2,273 | $-1,328 | $1,406 | $3,549 | $5,648 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,818 | -8,717 | -5,983 | -3,783 | -1,687 |
| Free Cash Flow | -2,818 | -8,717 | -5,983 | -3,783 | -1,687 |